- Filed
- Oct 4, 2023 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Sep 30, 2023 | 76.23M sh |
| Cash And Equivalents | Q2 2024 · Aug 31, 2023 | $292.19M |
| Cash And Equivalents | Q2 2024 · Feb 28, 2023 | $321.08M |
| Current Liabilities | Q2 2024 · Aug 31, 2023 | $109M |
| Current Liabilities | Q2 2024 · Feb 28, 2023 | $119.41M |
| Total Liabilities | Q2 2024 · Aug 31, 2023 | $416.68M |
| Total Liabilities | Q2 2024 · Feb 28, 2023 | $429.28M |
| Current Assets | Q2 2024 · Aug 31, 2023 | $336.26M |
| Current Assets | Q2 2024 · Feb 28, 2023 | $365.95M |
| Total Assets | Q2 2024 · Aug 31, 2023 | $854.32M |
| Total Assets | Q2 2024 · Feb 28, 2023 | $903.07M |
| Shares Diluted | Q2 2024 · Aug 31, 2022 | 70.48M sh |
| Shares Diluted | Q2 2024 · Aug 31, 2022 | 70.25M sh |
| Capex | Q2 2024 · Aug 31, 2022 | $1.41M |
| Operating Cash Flow | Q2 2024 · Aug 31, 2022 | −$33.45M |
| Stockholders Equity | Q2 2024 · Aug 31, 2022 | $506.31M |
| Stockholders Equity | Q2 2024 · May 31, 2022 | $534.51M |
| Stockholders Equity | Q2 2024 · Feb 28, 2022 | $855.79M |
| Eps Diluted | Q2 2024 · Aug 31, 2022 | −$0.66 |
| Eps Diluted | Q2 2024 · Aug 31, 2022 | −$5.54 |
| Eps Basic | Q2 2024 · Aug 31, 2022 | −$0.66 |
| Eps Basic | Q2 2024 · Aug 31, 2022 | −$5.54 |
| Sga Expense | Q2 2024 · Aug 31, 2022 | $21.02M |
| Sga Expense | Q2 2024 · Aug 31, 2022 | $41.26M |
| Net Income | Q2 2024 · Aug 31, 2022 | −$46.52M |
| Net Income | Q2 2024 · Aug 31, 2022 | −$389.35M |
| Net Income | Q2 2024 · May 31, 2022 | −$342.82M |
| Operating Income | Q2 2024 · Aug 31, 2022 | −$45.91M |
| Operating Income | Q2 2024 · Aug 31, 2022 | −$391.95M |
| Revenue | Q2 2024 · Aug 31, 2022 | $87.64M |
| Revenue | Q2 2024 · Aug 31, 2022 | $173.17M |